Phosphatases in tumor cell immune escape: a perspective based on the camouflage, coercion, cytoprotection

Chencheng Zhang1,2,3, Xinyue Qiu4, Weidong Shi5

  • 1Cancer Research Center, Nantong Tumor Hospital, Nantong, China.

Insights

Protein phosphatases are key regulators of tumor immune evasion, acting as molecular switches. Targeting these phosphatases offers a promising strategy for overcoming drug resistance and developing next-generation cancer immunotherapies.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cancer Research

Background:

  • Tumor immune evasion is a major obstacle in cancer treatment.
  • Understanding immune evasion mechanisms is vital for developing new immunotherapies.

Purpose of the Study:

  • To explore the role of protein phosphatases in tumor immune evasion.
  • To systematically review phosphatase regulatory networks within the "three Cs" framework (camouflage, coercion, cytoprotection).

Main Methods:

  • Literature review focusing on protein phosphatases and tumor immune evasion.
  • Analysis of phosphatase roles in immune cell recognition, function, and resistance to attack.

Main Results:

  • Protein phosphatases act as "dynamic molecular switches" in tumor immune evasion.
  • Their regulatory networks influence tumor cell recognition, immune cell inhibition, and resistance to immune attack.

Conclusions:

  • Targeting phosphatase regulatory networks holds potential for overcoming drug resistance in cancer immunotherapy.
  • Intervening in key phosphatase nodes can lead to synergistic regulation for next-generation immunotherapies.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K